Oral-systemic link has been termed Periodontal Medicine. Significance: Periodontal disease is preventable and readily treatable, thus providing many new opportunities for preventing and improving several systemic diseases.
FOCAL INFECTION: Localized or Generalized infection caused by dissemination of microorganisms or toxic products from focus of infection.
FOCUS OF INFECTION Confined area that
(1) contains pathogenic microorganisms
(2) can occur anywhere in body
Diseases/Conditions affected by periodontitis
A PREGNANCY, PREECLAMPSIA
B ISCHEMIC HEART DISEASES, STROKE
C DIABETES MELLITUS
D PNEUMONIA, COPD
E OSTEOPOROSIS
F CANCER
G ALZHEIMER’S DISEASE
H. RHEUMATOID ARTHRITIS
Epidemiology of gingival & periodontal diseasesChetan Basnet
It is the “study of the distribution and determinants of health related states or events in a specified population, and the application of this study to control of health problems.”
-John M. Last(1988)
Oral-systemic link has been termed Periodontal Medicine. Significance: Periodontal disease is preventable and readily treatable, thus providing many new opportunities for preventing and improving several systemic diseases.
FOCAL INFECTION: Localized or Generalized infection caused by dissemination of microorganisms or toxic products from focus of infection.
FOCUS OF INFECTION Confined area that
(1) contains pathogenic microorganisms
(2) can occur anywhere in body
Diseases/Conditions affected by periodontitis
A PREGNANCY, PREECLAMPSIA
B ISCHEMIC HEART DISEASES, STROKE
C DIABETES MELLITUS
D PNEUMONIA, COPD
E OSTEOPOROSIS
F CANCER
G ALZHEIMER’S DISEASE
H. RHEUMATOID ARTHRITIS
Epidemiology of gingival & periodontal diseasesChetan Basnet
It is the “study of the distribution and determinants of health related states or events in a specified population, and the application of this study to control of health problems.”
-John M. Last(1988)
Biologic width - Importance in Periodontal and Restorative DentistryDr.Shraddha Kode
Biologic width plays a vital role for preservation of the periodontal health. This concept involves the dimensions of the epithelial and connective tissue attachment between the base of the sulcus and the alveolar crest which if involved can lead to gingival inflammation and gingival recession.
This seminar explains various periodontal risk assessment tools at subject, tooth and site level risk assessment. Also, SPT with adjunct use of antimicrobials by professional and to be used by personals. Maintenance care for the implant patients has also been described with different conditions. The role played by dentist and by patient is being explained in flowcharts. And at last complications during SPT is described with references.
Biologic width - Importance in Periodontal and Restorative DentistryDr.Shraddha Kode
Biologic width plays a vital role for preservation of the periodontal health. This concept involves the dimensions of the epithelial and connective tissue attachment between the base of the sulcus and the alveolar crest which if involved can lead to gingival inflammation and gingival recession.
This seminar explains various periodontal risk assessment tools at subject, tooth and site level risk assessment. Also, SPT with adjunct use of antimicrobials by professional and to be used by personals. Maintenance care for the implant patients has also been described with different conditions. The role played by dentist and by patient is being explained in flowcharts. And at last complications during SPT is described with references.
The paradigm shift in the way we are treating periodontal disease necessitates the use of modifiable and non-modifiable risk factors. This presentation reviews the most recent evidence regarding periodontal disease diagnosis and maintenance.
Introduction
Landmarks in periodontal classification
Need for classification
Classification 1989 – with limitation
Classification 1993 – with limitation
Classification 1999 – changes made from 1989 classification and its limitation
Consensus report 2017classification
Classification 2017
Key features in 2017 classification
Gingival and periodontal health – induced and reduced periodontium
Gingivitis – biofilm induced
Gingivitis – non biofilm induced
Conclusion
References
Biomarker is an objective measure that has been evaluated and confirmed either as an indicator of physiologic health, a pathogenic process or a pharmacologic response to a therapeutic intervention. Biomarkers, whether produces by normal healthy individuals or by individuals affected by specific systemic diseases, are tell tale molecules that could be used to monitor health status, disease onset, treatment response and outcome.The biomarkers can help for the determination of present as well as future disease activity along with diagnosis and previous periodontal diseases.
This short course reveals some of the studies that show how oral health affects systemic health. Inflammation is the root cause of all the trouble, and the mouth is the most under evaluated sources of the inflammation.
Comparative Evaluation of Serum Tumor Necrosis Factor a in Health and Chronic...Dr. Anuj S Parihar
Background: Tumor necrosis factor‑alpha (TNF‑α), a “major inflammatory cytokine,” not only plays an important role in periodontal destruction but also is extremely toxic to the host. Till date, there are not many studies comparing the levels of TNF‑α in serum and its relationship to periodontal disease.
Aim: Our study aimed to compare the serum TNF‑α among the two study groups, namely, healthy controls and chronic periodontitis patients and establish a correlation between serum TNF‑α and various clinical parameters. Hence, an attempt is made to estimate the level of TNF‑α in serum, its relationship to periodontal disease and to explore the possibility of using the level of TNF‑α in serum as a biochemical “marker” of periodontal disease. Materials and Methods: Forty individuals
participated in the study and were grouped into two subgroups. Group A – 20 systemically and periodontally healthy controls. Group B – twenty patients with generalized chronic periodontitis.
The serum samples were assayed for TNF‑α levels by enzyme‑linked immunosorbent assay method.
Results: The mean serum TNF‑α cytokines for Group B Generalized chronic periodontitis (GCP) was 2.977 ± 1.011, and Group A (healthy) was 0.867 ± 0.865. The range of serum TNF‑α was from (0.867 to 2.977). Serum TNF‑α cytokines had highly significant correlation with all clinical parameters (plaque index, probing pocket depth, clinical attachment loss, and gingival index) among all study participants (P = 0.001). Conclusion: These observations suggest a positive association
between periodontal disease and increased levels of TNF‑α in serum. It can be concluded that there is a prospect of using the estimation of TNF‑α in serum as a “marker” of periodontal disease in future. However, it remains a possibility that the absence or low levels of TNF‑α in serum might indicate a stable lesion and elevated levels might indicate an active site but only longitudinal studies taking into account, the disease “activity” and “inactivity” could suggest the possibility of using
TNF‑α in serum as an “Indicator” of periodontal disease.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Periodontics & Rheumatoid arthritis
1.
2. Periodontal Status Correlates With
Anti-citrullinated Protein Antibodies In First
Degree Relatives Of Individuals With
Rheumatoid Arthritis
PRESENTED BY :- DR K. ABHILASHA
MODERATED BY :- DR FOUZIA TARANNUM
DEPARTMENT OF PERIODONTICS
M. R. AMBEDKAR DENTAL COLLEGE & HOSPITAL, BENGALURU
3. PRESENTATION LAYOUT
HISTORICAL BACKDROP
PERIODONTITIS
ASSOCIATION WITH SYSTEMIC
DISEASE
RHEUMATOID ARTHRITIS (RA)
WHAT IS RA?
PERIODONTAL CO-RELATION
RELATED STUDIES
ARTICLE
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSION
CLINICAL RELEVANCE
REFERENCES
4. HISTORICAL BACKDROP
• Hippocrates (460-370BC) – noted a case of rheumatism cured after infected
tooth extraction.
• Benjamin Rush (1745-1813) – recognized relation of oral infection to
general health.
• W. D. Miller (1853-1907) – proposed oral infections as the cause of many
diseases.
5. HISTORICAL BACKDROP
• G.V.Black – important part of dental profession in preserving general
health.
• Frank Billings, Edward C. Rosenow, Charles H. Mayo – interested in the
same concept.
• William Hunter (1861-1937) – indicated dentistry as a cause of what he
called “oral sepsis” – that caused rheumatic & other chronic diseases.
6. PERIODONTITIS
• Periodontitis (PD) is a chronic inflammatory disease where resident cells and
preformed mediators induce leukocyte infiltration and progressive destruction
of the tooth supporting tissues as a result of interaction between bacterial
products, cell populations, and mediators in disease-susceptible individuals.
• Results in irreversible attachment loss, bone destruction and tooth loss
eventually.
• The primary aetiology of PD is the dental biofilm (Löe et al.,1965) while the
host inflammatory response causes the resulting tissue damage (Bartold et al.,
2013).
7. PERIODONTITIS
• Periodontitis differs from many other types of infections since it is not caused
by a single bacterium but by a group of bacteria.
• Although more than 500 different types of bacteria have been isolated from the
oral cavity, Actinobacillus actinomycetemcomitans and Porphyromonas
gingivalis have been considered the major pathogenic species in destructive
periodontal disease.
• Other subgingival species involved include Prevotella intermedia, Tanerella
forsythus, Fusobacterium nucleatum, Campylobacter rectus, Eikenella corrodens,
Treponema denticola, Peptostreptococcus and some other species.
8.
9. ASSOCIATION WITH SYSTEMIC DIESEASE
• There is a substantial microbial and inflammatory burden associated with human
periodontal disease, and considerable evidence is accumulating that this systemic
burden may contribute to specific systemic diseases and conditions.
• The concept that oral diseases and systemic diseases influence each other goes back
to the theory of focal infection.
• In 1891, Miller published his theory regarding focal infection in which he indicated that
microorganisms and their products are able to access parts of the body that are
adjacent to or distant from the mouth.
10. ASSOCIATION WITH SYSTEMIC DIESEASE
• In recent years, the concept of focal infection has changed and now mostly
relies on the correlation between chronic periodontitis and systemic diseases.
• At present, it is generally known that a patient’s oral status is connected with
their systemic health, as poor oral health may cause serious underlying diseases
concomitantly and may predispose patients to developing other systemic
diseases.
11. ASSOCIATION WITH SYSTEMIC DIESEASE
Oral-hematogenous spread of periodontal pathogens and
direct effects to target organs.
Transtracheal spread of periodontal pathogens and direct
effects to target organs.
Oral-hematogenous spread of cytokines and antibodies with
effects at distant organs
The mechanisms by which periodontal infections may influence systemic health
have been described as follows:
13. RHEUMATOID ARTHRITIS
• Rheumatoid arthritis (RA) is a chronic inflammatory disorder of autoimmune origin that
may affect many tissues and organs but principally attacks the joints, producing a
nonsuppurative proliferative and inflammatory synovitis.
• The current understanding of RA pathogenesis postulates that the activity of
peptidil arginine deiminase (PAD), an enzyme that transforms arginine into
citrulline, which causes a post-translational modification in structural proteins.
• In addition, the formation of anti-citrullinated protein antibodies (ACPA) and
rheumatoid factor (RF) is almost unique to this disease, these antibodies being
a marker of aggressive RA.
37. Newer assays detect non-cyclic citrullinated peptides; the term anti-citrullinated peptide antibody (ACPA)
has thus replaced anti-cyclic citrullinated peptide (anti-CCP) antibody.
38. RHEUMATOID ARTHRITIS
• CLINICAL FEATURES:-
• The incidence of RA increases between 25 and 55 years of age, MORE IN FEMALES
AS compared to male.
• The presenting symptoms of joint pain in RA typically result from inflammation of
the joints, tendons, and bursae.
• Extra-articular manifestations may develop during the clinical course of RA in up
to 40% of patients, even prior to the onset of arthritis.
40. Correlation Between Rheumatoid Arthritis And Periodontitis
• There is evidence that periodontitis and RA share genetic risk factors such as the HLA-DRB1
allele of the MHC class II molecules.
• Similarly, environmental risk factors, such as smoking, socioeconomic status and obesity, may
influence both diseases.
• In addition to that Porphyromonas gingivalis, a Gram-negative, anaerobic bacterium, by
releasing a specific deaminase is able to induce protein citrullination, which stimulate ACPA
formation in RA patients.
• In severe periodontitis, the chronic exposure of citrullinated proteins and the subsequent
development of autoantibodies explain the reported association between periodontitis and
RA.
47. AIM OF THE STUDY
To Evaluate Periodontal Status In First-
degree Relatives Of Patients With
Rheumatoid Arthritis (FDR-RA) And Detect
Correlation With Presence Of Anti-
citrullinated Protein Antibodies (ACPA)
55. MATERIALS AND METHODS
STUDY DESIGN
• This is a nested case-control study within a larger cohort of individuals
at risk for RA.
• The Ethical Committee on human clinical research of the
Canton of Geneva approved the project (CER 08-102).
• Participants were contacted by phone and informed verbally
and in writing about the study, and all provided written
informed consent prior to dental examination.
56. MATERIALS AND METHODS
• The SCERRN-RA study is a prospective cohort of FDR-RA, comprising subjects
without a diagnosis of RA at enrolment.
• Cases were defined by the presence of systemic autoimmunity associated with
RA, defined by ACPA+, which was operationally characterized by a positive
result to any of the anti-cyclic citrullinated peptide antibodies tests (anti-CCP
2.0, 3.0 or 3.1) performed at any time during follow-up.
• Auto-antibodies were measured using the following commercially available
ELISA kits: anti-CCP 2, anti-CCP3 or anti-CCP 3.1
STUDY POPULATION
57. MATERIALS AND METHODS
• . ACPA positivity was defined according to the manufactures’ cut-off values
(anti-CCP2 >25 U/mL, anti-CCP 3 and 3.1 >20 U/mL).
• Controls were defined as individuals without any autoantibody positivity.
• Individuals with complete clinical information and available ACPA status
were included.
58. 52 ACPA+ were contacted
34 agreed for dental examination
18 refused to participate CASES
(32 females and 2 males, aged 22 to 81 years; mean age: 56.5 + 14.4 years
65 ACPA- were recruited
(61 females and 4 males, aged 24 to 83 years; mean age: 56.3 + 12.1 years)
NONE
CONTROLS
59. MATERIALS AND METHODS
• The following information was retrieved from the medical and dental
history:
age,
gender,
comorbidities,
general medication,
shared epitope (SE),
smoking (former, light (<10/d) or heavy (>10/d) smoker),
oral hygiene habits
CLINICAL EXAMINATION
60. MATERIALS AND METHODS
• A full-mouth examination at six sites on each tooth was performed by calibrated
periodontist.
• The following clinical parameters were recorded:
• Gingival Index (GI) (Löe and Silness 1963),
• Plaque Index (PI) (Löe and Silness 1963),
• Probing depth (PD) using a manual probe,
• Bleeding On probing (BOP) recorded as present or absent within 30 seconds,
• Recession (Rec) as the vertical distance between the cement-enamel junction and the
gingival margin,
• Furcation involvement and
• Tooth mobility.
CLINICAL EXAMINATION
61. MATERIALS AND METHODS
• Periodontitis was classified as:-
• Mild periodontitis one or more teeth with interproximal sites showing >4 mm CAL and
>4 mm PD;
• Moderate periodontitis as two or more non-adjacent teeth with interproximal sites
showing >5 mm CAL and > 4 mm PD;
• Severe periodontitis, as two or more non-adjacent teeth with interproximal sites
showing > 6 mm CAL and > 4 mm PD.
• Diagnosis of gingivitis was given when the BOP score was > 10% and the PD <3 mm.
• Healthy periodontal status was attributed when the BOP score was less than 10%.
CLINICAL EXAMINATION
62. MATERIALS AND METHODS
• ACPA+ and ACPA- participants were described using frequencies and percentages
for categorical variables and mean and standard deviations for continuous
variables.
• Two groups were compared using conditional logistic regression.
• Further the independent associations of periodontal status with clinical variables
using mixed effects logistic regression to account for the matched structure of the
data were examined.
• All analyses were conducted using R v3.5.1 with a significance threshold set at
p<0.05.
STATISTICAL ANALYSIS
77. CONCLUSION
• In conclusion, they found a high prevalence of periodontitis in ACPA+ FDR-RA as
compared to ACPA- subjects from the same cohort, strengthening the hypothesis
that periodontitis may be a major risk factor in the development of RA.
• The study suggests that specific guidelines should be given to both medical and
dental health practitioners to decrease the risk for developing periodontitis in this
population.
• Longitudinal studies are needed to further elucidate the impact of such preventive
interventions on subsequent RA development and to establish the predictive value
of the periodontal status on the risk of developing RA.
78. CLINICAL RELEVANCE
• Scientific rationale for the study
• A relationship between periodontitis and rheumatoid arthritis has been established. Several years
before the clinical manifestations of rheumatoid arthritis (RA), anti-citrullinated protein antibodies
(ACPAs) are present in the serum of subjects who are at risk of RA on the basis of genetic and
environmental factors. The role of these autoantibodies in the link between periodontitis and RA
development is still unclear.
• Principal findings
• Higher prevalence and severity of periodontitis and poorer periodontal conditions were found in
ACPA positive compared to ACPA negative subjects.
79. CLINICAL RELEVANCE
Practical implications
• Dentists should incorporate the family history of RA into risk
assessment and treatment planning.
• Physicians need to be aware on the implication of periodontal
disease in RA development and recommend regular dental
assessments and early treatment of periodontal disease.
80. REFERENCES
• Text book of Periodontology, NEWMANN & CARANZZA, 13TH EDITION
• HARRISON’S Principles of Internal Medicine, 20TH EDITION
• Taylor GW. Periodontal health and systemic disorders. J Can Dent Assoc.
2002;68(3):188-92.
• Chiranjeevi T, Prasad OH, Prasad UV, Kumar AK, Chakravarthi VP, Rao PB, Sarma PV.
Identification of microbial pathogens in periodontal disease and diabetic patients of
south indian population. Bioinformation. 2014;10(4):241.
• Lee YH, Lew PH, Cheah CW, Rahman MT, Baharuddin NA, Vaithilingam RD. Potential
mechanisms linking periodontitis to rheumatoid arthritis. Journal of the International
Academy of Periodontology. 2019 Jul;21(3):99-110.
81. REFERENCES
• Igari K, Kudo T, Toyofuku T, Inoue Y, Iwai T. Association between periodontitis and
the development of systemic diseases. Oral Biol Dent. 2014;2(1):4.
• Kaur S, Bright R, Proudman SM, Bartold PM. Does periodontal treatment influence
clinical and biochemical measures for rheumatoid arthritis? A systematic review
and meta-analysis. InSeminars in arthritis and rheumatism 2014 Oct 1 (Vol. 44,
No. 2, pp. 113-122). WB Saunders.
• Araújo VM, Melo IM, Lima V. Relationship between periodontitis and rheumatoid
arthritis: review of the literature. Mediators of inflammation. 2015;2015.